PepVax, Inc. has developed a novel DNA-based drug delivery and development platform, called SMARTmid™, to make safer and more effective treatments inside the patient (Intusic™) using a “Trojan Horse” approach. The company is currently focusing on treatment efforts for COVID-19.
Org chart
This company has no org chart yet
Teams
This company has no teams yet
Offices
Solace
2 followers
Merck
348 followers
EveryLife Foundation for Rare Diseases
1 follower
A
ALS Therapy Development Institute
3 followers
Daymark Health
1 follower
UC Health
6 followers
Johnson & Johnson
671 followers
Truveta
5 followers
Thermo Fisher Scientific
284 followers
Genentech
226 followers
Regeneron
182 followers
Vertex Pharmaceuticals
111 followers